Dear patients,

(from left to right) Professor Esther Troost, Professor Mechthild Krause @HZDR/Rainer Weisflog

Thank you for taking an interest in research at OncoRay – National Center for Radiation Research in Oncology. At OncoRay, some 80 scientists pool their energies to decisively improve the treatment of cancer by the administration of radiation therapy.

To this end, we investigate quantifiable biological factors of tumors, such as genetic modifications and oxygen content, which can influence the effectiveness of radiotherapy. On the basis of these factors, we are able to tailor make our therapies to suit the patients receiving them. We also improve and develop technical devices for radiation therapy as well as for imaging during and after treatments. All of this is designed to increase the chances of recovery and reduce the occurrence of potential side effects.

In addition to improving classic radiation treatment using ultra-hard x-ray beams (photons), we also research innovative methods of proton therapy. Since late 2014, it has been possible to treat patients at University Proton Therapy Dresden (UPTD) with proton rays. Protons are tiny charged particles that impact the tumor with high precision and do less damage to healthy tissue.

We test promising research results in clinical studies. Thanks to this direct linkage of scientific research and medical care, our patients in the Department of Radiotherapy and Radiooncology benefit from state-of-the-art therapy.

Professor Mechthild Krause, Director of the OncoRay Center, Director of the Department of Radiotherapy and Radiooncology at Dresden University Hospital and Director of the Institute for Radiooncology – OncoRay at the Helmholtz-Zentrum Dresden-Rossendorf
Professor Esther Troost, Deputy Director of the Department of Radiotherapy and Radiooncology at Dresden University Hospital und head of the Department of Image Guided Radiation Therapy at the HZDR-Institute for Radiooncology – OncoRay and at OncoRay